Nav: Home

Undetected Ebola infection in international healthcare workers very unlikely

May 16, 2017

Undiagnosed Ebola virus infection was probably very rare in international workers who were deployed during the 2013-2015 outbreak of the virus in West Africa, despite mild and asymptomatic cases of Ebola being known to occur, according to new research published in the journal PLOS Medicine.

As part of the study, more than 250 UK and Ireland healthcare and other workers were tested for Ebola virus antibodies after returning from West Africa -- no evidence of missed infections was found. This suggests that the vast majority of volunteers were kept safe by Personal Protective Equipment (PPE) and the Ebola treatment centre procedures in place. However, the study also found that potentially avoidable events putting frontline workers at risk of infection were quite common during the outbreak, with one in six participants classified as having 'near miss' exposure events.

In what is believed to be the first study of the prevalence of Ebola infection in international responders the research team, led by the London School of Hygiene & Tropical Medicine and funded by the Wellcome Trust, enrolled 300 UK and Ireland healthcare and other frontline workers¹ for the study and sent them oral fluid collection devices. Among the 268 respondents who returned their samples, 99% showed negative results on an antibody test which the authors had already proved gave very accurate results in Sierra Leone2. The remaining two people, who had no known exposure or symptoms, had positive results, but follow-up testing using different methods was negative, making Ebola virus infection very unlikely.The research team, led by the London School of Hygiene & Tropical Medicine and funded by the Wellcome Trust, enrolled 300 UK and Ireland healthcare and other frontline workers¹ for the study and sent them oral fluid collection devices. Among the 268 respondents who returned their samples, 99% showed negative results on an antibody test which the authors had already proved gave very accurate results in Sierra Leone2. The remaining two people, who had no known exposure or symptoms, had positive results, but follow-up testing using different methods was negative, making Ebola virus infection very unlikely.

Lead author Dr Catherine Houlihan from the London School of Hygiene & Tropical Medicine and UCL said: "The 2013-2015 Ebola outbreak was unprecedented - the commitment and bravery of those who volunteered saved many lives. We know a small number of international health workers were infected with the virus but we thought it was possible that some infections had been missed, as we know asymptomatic or unrecognised infections can occur. However, our research suggests undetected infection in this group is, at most, a very rare event, and that the Personal Protective Equipment did its job well."

Participants, who included clinicians, laboratory workers and epidemiologists, also completed an online survey which asked if they experienced possible exposure to Ebola virus while in West Africa. Using 268 respondents' descriptions, 16% (43 people) were identified as having 'near miss' exposure events.

27 respondents reported experiencing very low-risk incidents³ such as having a facemask dislodged. Ten were identified as having low-risk exposure events which were classified as having direct physical contact with an Ebola patient who does not have vomiting, diarrhoea, or bleeding. Five faced an intermediate risk incident with one respondent reporting 'being vomited on while wearing just gloves' and not full PPE, and one experienced the high-risk incident of a 'sharp injury with a broken vial of medication inside the 'red zone' with dirty and contaminated gloves'. The antibody tests showed that none of these individuals had any evidence of infection with Ebola.

Participants reported PPE suits torn by catching on doorways or corners, PPE breaches in Ebola laboratories, such as torn outer gloves, as well as the additional anxiety and distress these incidents caused them.

Dr Catherine Houlihan said: "The scale of the outbreak meant frontline workers faced demanding and draining circumstances. Participants have given crucial insights which provide valuable lessons for future Ebola outbreaks. Regular debriefing after work in the clinical red zone or laboratory, and blame-free reporting of near misses, should be part of routine practice in emergency treatment response work. Simple changes such as banning glass vials in the red zone could reduce the number of staff experiencing skin lacerations, and further testing of the robustness and fit of PPE suits, could potentially save health workers' lives in the future."

Participants, who were based mostly in Sierra Leone, were also asked whether they experienced fever or diarrhoea while in West Africa or within one month of their return, and if so whether they were tested for Ebola virus at the time. Despite symptoms in 21% (57/268) of the respondents, 70% were not tested, with those still in West Africa much less likely to receive a test -- 11 out of 17 who fell ill on their return were tested, but just one person out of 21 who fell ill in West Africa was tested.

Dr Houlihan said: "This study provides reassuring evidence about the lack of Ebola infection in individuals who had not previously been tested for the virus. However, the high proportion of health workers who didn't get tested when falling ill in West Africa, coupled with returnees' potential exposure to Ebola, are a concern. Although we don't know how many health workers reported being ill and were assessed to decide if they needed to be tested, protocols for the management of possible exposure to the virus, and for the management of illness, may need reviewing and to be standardised across organisations that deploy staff to outbreaks.

"Importantly, these protocols must be applicable to national as well as international staff. West African responders worked in large numbers from the early stages of the epidemic right through to its conclusion, and were undoubtedly at the highest risk. We must also ensure that every individual who works in these high-risk settings receives strong support and is thoroughly trained ahead of starting work, including on the use of PPE, how to reduce risk in and out of the red zone, and what to do if they think they have been exposed or if they become unwell."

The authors acknowledge limitations of the study including that not all returning responders were included and participants were not a random sample. It is therefore possible that those who knew of possible exposures, or who had had symptoms, were particularly keen to participate. Since these were the people who were most likely to have been infected, the absence of undiagnosed infections is reassuring.
Notes to Editors

Catherine F. Houlihan, Catherine R. McGowan, Steve Dicks, Marc Baguelin, David A. J. Moore, David Mabey, Chrissy h. Roberts, Alex Kumar, Dhan Samuel, Richard Tedder, Judith R. Glynn. Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014-2016: A cross-sectional study. PLOS Medicine. DOI:10.1371/journal.pmed.100

1Invitations to participate in the study were sent to individuals known to the authors and through organisations supporting emergency medical team deployment involving UK-based staff, including NGOs, UK government-affiliated institutions, and the London School of Hygiene & Tropical Medicine

²Glynn et al. Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus. Lancet Infect Diseases.DOI:10.1016/S1473-3099(17)30111

³Based on respondents' free-text descriptions and using a published risk assessment method, the risk of infection in individuals was categorised as:
  • Very low (27 people) - living or working with someone with undiagnosed EVD but no direct physical contact; breaches in PPE with no visible contamination or broken skin exposure

  • Low (10) - direct physical contact with patient who does not have vomiting, diarrhoea, or bleeding.

  • Intermediate (5), direct physical contact with a patient with diarrhoea, vomiting, or bleeding; direct contact with bodily fluids from a patient with EVD.

  • High (1) - exposure of mucous membranes or broken skin to bodily fluids from an EVD patient, or sharp injury from a needle/other used on an EVD patient (not freshly used or not hollow-bore needle).

About the London School of Hygiene & Tropical Medicine

The London School of Hygiene & Tropical Medicine is a world-leading centre for research and postgraduate education in public and global health, with more than 4,000 students and 1,000 staff working in over 100 countries. The School is one of the highest-rated research institutions in the UK, and among the world's leading schools in public and global health. Our mission is to improve health and health equity in the UK and worldwide; working in partnership to achieve excellence in public and global health research, education and translation of knowledge into policy and practice.

London School of Hygiene & Tropical Medicine

Related Ebola Articles:

Ebola antibodies at work
Scientists in Israel and Germany show, on the molecular level, how an experimental vaccine offers long-term protection against the disease.
Half of Ebola outbreaks undetected
An estimated half of Ebola virus disease outbreaks have gone undetected since it was discovered in 1976, according to research published in PLOS Neglected Tropical Diseases.
Half of Ebola outbreaks go undetected, study finds
Half of Ebola outbreaks have gone undetected since the virus was discovered in 1976, scientists at the University of Cambridge estimate.
Protecting those on the frontline from Ebola
Online training developed at the Medical University of South Carolina (MUSC) increased the knowledge of health care workers about effective prevention of Ebola up to 19 percent and reduced critical errors to 2.3 percent in a small MUSC cohort.
Another piece of Ebola virus puzzle identified
A team of researchers have discovered the interaction between an Ebola virus protein and a protein in human cells that may be an important key to unlocking the pathway of replication of the killer disease in human hosts.
How the human immune system protects against Ebola
'The current approach for treatment of filovirus infections with antibody cocktails tested in animal models utilizes the principle of targeting of non-overlapping epitopes.
How to slow down Ebola
The phylogenetic tree of the 2013-2016 Ebola epidemic doesn't just tell us how the Ebola virus was able to evolve: it also reveals which events and preventive measures accelerated or slowed down its spread.
Study provides further insight into how Ebola affects the eye
A new study, conducted by the researchers from the University of Liverpool, published in JAMA Ophthalmology identifies the specific characteristics of Ebola retinal lesions, which provide further clues as to how the virus travels to the retina and causes damage.
New breakthrough paving the way for universal Ebola therapeutic
A new collaborative study has identified and studied Ebola antibodies that could be used to design universal therapeutics that are effective against many different Ebola species.
Preprints accelerated between Ebola and Zika epidemics
Preprints -- scientific manuscripts that are posted at a recognized online repository before peer review -- have the potential to speed up the reporting of scientific research in infectious disease outbreaks, argue Michael Johansson and colleagues in an Essay in PLOS Medicine.
More Ebola News and Ebola Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

Accessing Better Health
Essential health care is a right, not a privilege ... or is it? This hour, TED speakers explore how we can give everyone access to a healthier way of life, despite who you are or where you live. Guests include physician Raj Panjabi, former NYC health commissioner Mary Bassett, researcher Michael Hendryx, and neuroscientist Rachel Wurzman.
Now Playing: Science for the People

#544 Prosperity Without Growth
The societies we live in are organised around growth, objects, and driving forward a constantly expanding economy as benchmarks of success and prosperity. But this growing consumption at all costs is at odds with our understanding of what our planet can support. How do we lower the environmental impact of economic activity? How do we redefine success and prosperity separate from GDP, which politicians and governments have focused on for decades? We speak with ecological economist Tim Jackson, Professor of Sustainable Development at the University of Surrey, Director of the Centre for the Understanding of Sustainable Propserity, and author of...
Now Playing: Radiolab

An Announcement from Radiolab